Review of diphtheria, tetanus and pertussis vaccines in clinical development

Immunogenicity and safety study of a new DTaP–IPV–Hep B–PRP-T combined vaccine compared to a licensed DTaP–IPV–Hep B//PRP-T comparator, both concomitantly administered with a 7-valent pneumococcal conjugate vaccine at 2, 4, and 6 months of age in Thai infants

(2011) Pope Kosalaraksa et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Immunogenicity and Safety of an Investigational Fully Liquid Hexavalent Combination Vaccine Versus Licensed Combination Vaccines at 6, 10, and 14 Weeks of Age in Healthy South African Infants

(2011) Shabir A. Madhi et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Booster Vaccination After Neonatal Priming with Acellular Pertussis Vaccine

(2010) Markus Knuf et al.   JOURNAL OF PEDIATRICS

Acellular Pertussis Vaccine at Birth and One Month Induces Antibody Responses By Two Months of Age

(2010) Nicholas Wood et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Immunogenicity and safety of a novel yeast Hansenula polymorpha-derived recombinant Hepatitis B candidate vaccine in healthy adolescents and adults aged 10–45 years

(2010) Miguel W. Tregnaghi et al.   VACCINE

Safety and immunogenicity of three different formulations of a liquid hexavalent diphtheria–tetanus–acellular pertussis–inactivated poliovirus–Haemophilus influenzae b conjugate–hepatitis B vaccine at 2, 4, 6 and 12–14 months of age

(2010) Francisco Diaz-Mitoma et al.   VACCINE

Immunogenicity of a Whole-Cell Pertussis Vaccine with Low Lipopolysaccharide Content in Infants

(2009) T. Q. Zorzeto et al.   Clinical and Vaccine Immunology

Safety and immunogenicity of a hexavalent diphtheria–tetanus–acellular pertussis–inactivated poliovirus–Haemophilus influenzae b conjugate–hepatitis B vaccine at 2, 3, 4, and 12–14 months of age

(2009) Scott A. Halperin et al.   VACCINE

Neonatal Vaccination with an Acellular Pertussis Vaccine Accelerates the Acquisition of Pertussis Antibodies in Infants

(2007) Markus Knuf et al.   JOURNAL OF PEDIATRICS